VHCP Management II, LLC's Form 4 filing
Vistagen Therapeutics, Inc. (VTGN) · filed Jul 14, 2022
- Accession no.
- 0001209191-22-042152
- Filed
- Jul 14, 2022, 5:33 PM ET
- Trade date
- Jul 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $53.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| VHCP Management II, LLCCIK 0001602263 | 10% Owner |
| Venrock Healthcare Capital Partners II, L.P.CIK 0001602264 | 10% Owner |
| Koh Bong YCIK 0001615979 | 10% Owner |
| VHCP Co-Investment Holdings II, LLCCIK 0001615983 | 10% Owner |
| Shah Nimish PCIK 0001698082 | 10% Owner |
| Venrock Healthcare Capital Partners III, L.P.CIK 0001738048 | 10% Owner |
| VHCP Management III, LLCCIK 0001738053 | 10% Owner |
| VHCP Co-Investment Holdings III, LLCCIK 0001750761 | 10% Owner |
| Venrock Healthcare Capital Partners EG, L.P.CIK 0001808512 | 10% Owner |
| VHCP Management EG, LLCCIK 0001808518 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2022 | Common Stock | SSaleDisposed | −60,000 | $0.89 | −$53,400 | 20,637,286 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.